menu search

Bristol myers squibb (bmy) gains as market dips: what you should know

Bristol Myers squibb (BMY) closed the most recent trading day at $62.35, moving +0.1% from the previous...

December 28, 2021, 7:10 pm

Bristol myers squibb (bmy) gains as market dips: what you should know

Bristol Myers squibb (BMY) closed the most recent trading day at $62.35, moving +0.1% from the previous...

December 28, 2021, 7:10 pm

3 best biopharma stocks to buy during this industrywide fire sale

Affimed, Amgen, and Bristol Myers squibb are too cheap to ignore right now....

November 28, 2021, 10:00 am

3 best biopharma stocks to buy during this industrywide fire sale

Affimed, Amgen, and Bristol Myers squibb are too cheap to ignore right now....

November 28, 2021, 10:00 am

3 best biopharma stocks to buy during this industrywide fire sale

Affimed, Amgen, and Bristol Myers squibb are too cheap to ignore right now....

November 28, 2021, 10:00 am

Evotec expands neuroscience collaboration with bristol myers

Bristol Myers squibb & Co (NYSE: BMY) has expanded its neuroscience collaboration with Evotec SE (...

October 8, 2021, 9:36 am

Evotec expands neuroscience collaboration with bristol myers

Bristol Myers squibb & Co (NYSE: BMY) has expanded its neuroscience collaboration with Evotec SE (...

October 8, 2021, 9:36 am

Evotec expands neuroscience collaboration with bristol myers

Bristol Myers squibb & Co (NYSE: BMY) has expanded its neuroscience collaboration with Evotec SE (...

October 8, 2021, 9:36 am

Evotec expands neuroscience collaboration with bristol myers squibb to include novel cell type

INCLUDES NEW CELL TYPES FOR STUDYING MOLECULAR DISEASE SIGNATURES FOR DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES TRIGGERS...

October 8, 2021, 1:50 am

Evotec expands neuroscience collaboration with bristol myers squibb to include novel cell type

INCLUDES NEW CELL TYPES FOR STUDYING MOLECULAR DISEASE SIGNATURES FOR DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES TRIGGERS...

October 8, 2021, 1:50 am

Evotec expands neuroscience collaboration with bristol myers squibb to include novel cell type

INCLUDES NEW CELL TYPES FOR STUDYING MOLECULAR DISEASE SIGNATURES FOR DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES TRIGGERS...

October 8, 2021, 1:50 am

Bristol myers squibb (bmy) stock sinks as market gains: what you should know

In the latest trading session, Bristol Myers squibb (BMY) closed at $59.01, marking a -0.3% move from t...

October 7, 2021, 8:10 pm

Bristol myers squibb (bmy) stock sinks as market gains: what you should know

In the latest trading session, Bristol Myers squibb (BMY) closed at $59.01, marking a -0.3% move from t...

October 7, 2021, 8:10 pm

Bristol myers squibb (bmy) stock sinks as market gains: what you should know

In the latest trading session, Bristol Myers squibb (BMY) closed at $59.01, marking a -0.3% move from t...

October 7, 2021, 8:10 pm

Bristol myers' tyk2 inhibitor disappoints in mid-stage ulcerative colitis study

Bristol Myers squibb & Co (NYSE: BMY) has announced topline data from the Phase 2 LATTICE-UC study e...

October 7, 2021, 10:23 am

Bristol myers' tyk2 inhibitor disappoints in mid-stage ulcerative colitis study

Bristol Myers squibb & Co (NYSE: BMY) has announced topline data from the Phase 2 LATTICE-UC study e...

October 7, 2021, 10:23 am

Bristol myers' tyk2 inhibitor disappoints in mid-stage ulcerative colitis study

Bristol Myers squibb & Co (NYSE: BMY) has announced topline data from the Phase 2 LATTICE-UC study e...

October 7, 2021, 10:23 am


Search within

Pages Search Results: